CCND1 and mantle cell lymphoma: In one study, cyclin D1 was verified as an independent prognostic factor from the IPI and 5-year overall survival was significantly higher in cyclin D1-negative MCL than cyclin D1-positive MCL (86% vs. 30%) [37].